SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Winston Churchill Synthetic CCD

PatientWinston Churchill
Date of birth1947-11-30
IdentifiersMRN HR-ET001-SYN; SSN (made up) 000-01-8846
Document date2026-11-01
AuthorBeatrice Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care transition visit eight days after a minor ischemic stroke. Concerns: Wants to return to full work and to give a major speech within about three months; Fears another stroke, but does not want to give up cigars or his drinking habits entirely. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrelOne tablet by mouth dailyOral route2026-06-23 to 2026-07-14completedS
Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital)One tablet by mouth dailyOral route2026-06-23activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-23activeS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-26 to 2026-07-01completedS
Amlodipine 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-07-01 to 2026-07-29completedS
Lisinopril 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-07-15activeS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-07-29activeS

Procedures

ProcedureDatesStatusEvidence
MRI of the brain in the hospital: acute 12 mm lacunar infarct in the right internal capsule and corona radiata; chronic small-vessel white-matter changes in both hemispheres; no hemorrhage2026-06-23 to 2026-06-23completedS
CT angiography of the head and neck in the hospital: no carotid, vertebral, or intracranial stenosis or occlusion2026-06-23 to 2026-06-23completedS
Transthoracic echocardiography with bubble study in the hospital: normal left ventricular size and function, mild left ventricular hypertrophy, normal left atrium, no thrombus, no shunt2026-06-24 to 2026-06-24completedS
12-lead electrocardiogram: sinus rhythm 72/min, left ventricular hypertrophy by voltage, no atrial fibrillation2026-07-01 to 2026-07-01completedS
30-day ambulatory ECG monitoring: sinus rhythm throughout, occasional atrial ectopic beats, no atrial fibrillation or flutter2026-07-15 to 2026-08-14completedS
Outpatient physical and occupational therapy for left-sided weakness and hand dexterity, twice weekly, completed2026-07-06 to 2026-09-25completedS

Immunizations

DateVaccineStatusEvidence
2025-10-14High-dose influenza vaccine, 2025-2026 seasoncompletedS
2022-11-07Pneumococcal conjugate vaccine PCV20completedS
2024-09-23Respiratory syncytial virus vaccine, single dosecompletedS
2019-05-20Recombinant zoster vaccine, two-dose series completedcompletedS
2018-03-12Tdap vaccinecompletedS
2026-10-28High-dose influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
December 1941Chest pain at the White House after straining to open a window; read at the time as a heart attack, but no heart disease was found and the episode was probably musculoskeletal (disputed)R (CLM-0002)
December 1943Critical pneumonia in Tunis, treated with sulfonamidesD (CLM-0003)
August 1949First stroke, a less serious attack at Cap d'Ail described as spasm of a small arteryD (CLM-0004)
1950 to 1952Further cerebrovascular episodes, including transient ischemic attacks, from 1950 to 1952D (CLM-0004)
23 June 1953Stroke at a dinner at 10 Downing Street: left hemiparesis with a drooping mouth and slurred speech, worst on the third day; kept secret at the timeD (CLM-0005, CLM-0006)

Family History

RelativeConditionAge at deathEvidence
fatherDied in 1895 at 45 after a progressive illness with speech and hearing problems, dizziness, and numbness; cause disputed and not established in the cited source45R (CLM-0013)

Health Concerns

ConcernStatusEvidence
Wants to return to full work and to give a major speech within about three monthsactiveS
Fears another stroke, but does not want to give up cigars or his drinking habits entirelyactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 137 on 2026-07-29; Potassium [Moles/volume] in Serum or Plasma 4.6 on 2026-07-29; Creatinine [Mass/volume] in Serum or Plasma 1.12 on 2026-07-29; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 67 on 2026-07-29; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-07-29; Hemoglobin [Mass/volume] in Blood 14.2 on 2026-07-01; Platelets [#/volume] in Blood by Automated count 245 on 2026-07-01; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-07-01; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 on 2026-08-19; Total score [NIH Stroke Scale] 1 on 2026-07-29; Total score [MoCA] 27 on 2026-10-28; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-28; Total score [AUDIT-C] 5 on 2026-10-28; Cholesterol [Mass/volume] in Serum or Plasma 128 on 2026-08-19; Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 on 2026-08-19; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-08-19; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 58 on 2026-08-19; Modified rankin scale 1 on 2026-10-07 [S]

Strengths and supports: Supports: married and lives with his spouse; adult children; a large, devoted staff [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1953 strokeactiveconfirmed I69.354S — Synthetic modern diagnosis; the 1953 stroke remains D in the history.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis supported by the documented raised blood pressure after the 1953 stroke.
Nicotine dependence, cigars, six to eight a dayactiveconfirmed F17.290S — Synthetic coded diagnosis echoing the documented lifelong cigar smoking.
Orthostatic hypotension after antihypertensive intensification in hot weather, resolved after reducing amlodipineresolvedconfirmed I95.1S — Synthetic medication-related intercurrent problem at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-01Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-07-01Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-07-01Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-07-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M79mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-01Glucose [Mass/volume] in Serum or Plasma97mg/dL70-99 mg/dLNormalS
2026-07-01Hemoglobin [Mass/volume] in Blood14.2g/dL13.2-16.6 g/dLNormalS
2026-07-01Platelets [#/volume] in Blood by Automated count24510*3/uL150-400 10*3/uLNormalS
2026-07-01Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-07-01Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-56 U/LNormalS
2026-07-01Total score [NIH Stroke Scale]2{score}S
2026-07-01Total score [MoCA]26{score}S
2026-07-01Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-07-01Total score [AUDIT-C]8{score}S
2026-07-15Total score [NIH Stroke Scale]1{score}S
2026-08-19Cholesterol [Mass/volume] in Serum or Plasma128mg/dL<=199 mg/dLNormalS
2026-08-19Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=40 mg/dLNormalS
2026-08-19Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-08-19Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation58mg/dL<=99 mg/dLNormalS
2026-08-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-56 U/LNormalS
2026-08-19Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-08-19Total score [AUDIT-C]5{score}S
2026-10-07Modified rankin scale1{score}S
2026-10-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-07-29Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-07-29Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-07-29Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
2026-07-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-29Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-07-29Total score [NIH Stroke Scale]1{score}S
2026-10-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-10-28Total score [MoCA]27{score}S
2026-10-28Total score [AUDIT-C]5{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-07-01Body height168cmS
2026-07-01Body weight80kgS
2026-07-01Body mass index (BMI) [Ratio]28.3kg/m2S
2026-07-01Systolic blood pressure152mm[Hg]S
2026-07-01Diastolic blood pressure86mm[Hg]S
2026-07-01Heart rate72/minS
2026-07-01Respiratory rate16/minS
2026-07-01Body temperature36.7CelS
2026-07-01Oxygen saturation in Arterial blood by Pulse oximetry96%S
2026-07-15Body height168cmS
2026-07-15Body weight79.6kgS
2026-07-15Body mass index (BMI) [Ratio]28.2kg/m2S
2026-07-15Systolic blood pressure138mm[Hg]S
2026-07-15Diastolic blood pressure80mm[Hg]S
2026-07-15Heart rate70/minS
2026-07-15Respiratory rate16/minS
2026-07-15Body temperature36.6CelS
2026-07-15Oxygen saturation in Arterial blood by Pulse oximetry96%S
2026-08-19Body height168cmS
2026-08-19Body weight79kgS
2026-08-19Body mass index (BMI) [Ratio]28kg/m2S
2026-08-19Systolic blood pressure128mm[Hg]S
2026-08-19Diastolic blood pressure76mm[Hg]S
2026-08-19Heart rate70/minS
2026-08-19Respiratory rate16/minS
2026-08-19Body temperature36.7CelS
2026-08-19Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-10-07Body height168cmS
2026-10-07Body weight78.6kgS
2026-10-07Body mass index (BMI) [Ratio]27.8kg/m2S
2026-10-07Systolic blood pressure126mm[Hg]S
2026-10-07Diastolic blood pressure74mm[Hg]S
2026-10-07Heart rate68/minS
2026-10-07Respiratory rate16/minS
2026-10-07Body temperature36.6CelS
2026-10-07Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-29Body height168cmS
2026-07-29Body weight78.8kgS
2026-07-29Body mass index (BMI) [Ratio]27.9kg/m2S
2026-07-29Systolic blood pressure118mm[Hg]S
2026-07-29Diastolic blood pressure68mm[Hg]S
2026-07-29Heart rate76/minS
2026-07-29Respiratory rate16/minS
2026-07-29Body temperature36.8CelS
2026-07-29Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-10-28Body height168cmS
2026-10-28Body weight78.4kgS
2026-10-28Body mass index (BMI) [Ratio]27.8kg/m2S
2026-10-28Systolic blood pressure124mm[Hg]S
2026-10-28Diastolic blood pressure72mm[Hg]S
2026-10-28Heart rate68/minS
2026-10-28Respiratory rate16/minS
2026-10-28Body temperature36.6CelS
2026-10-28Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
2026-07-01Primary care transition visit eight days after a minor ischemic strokefinishedS
2026-07-15Two-week stroke review at the end of dual antiplatelet therapy, and neurology consultationfinishedS
2026-08-19Eight-week stroke and blood pressure review with lipid panel and rhythm-monitor resultsfinishedS
2026-10-07Three-month stroke review before returning to public speakingfinishedS
2026-07-29Same-day sick visit for lightheadedness on standingfinishedS
2026-10-28Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Aspirin with clopidogrel for 21 days after the minor stroke, then clopidogrel 75 mg alonecompletedGL-STROKE-2021, GL-CMID-2026S
Atorvastatin 80 mg with a lipid panel 4 to 12 weeks after starting, aiming for LDL cholesterol below 70 mg/dLcompletedGL-STROKE-2021, GL-CMID-2026S
Lower blood pressure below 130/80 with amlodipine and lisinopril, checking standing blood pressure at each visit and a basic metabolic panel 1 to 2 weeks after starting lisinoprilcompletedGL-STROKE-2021, GL-HTN-2025, GL-CMID-2026S
Neurology consultation to confirm the stroke mechanism, set the antiplatelet plan after the 21-day course, decide on prolonged cardiac rhythm monitoring, and advise on return to work and public speakingcompletedGL-STROKE-2021, GL-ARRH-2024S
Outpatient physical and occupational therapy for left-sided weakness, with fall-risk review at every visitcompletedGL-PCAS-2021, GL-CMID-2026S
PHQ-9 at the first visit and at each review while symptoms persist, MoCA again within the first year, and attention to post-stroke tearfulnesscompletedGL-PCAS-2021, GL-CMID-2026S
Brief interventions at every visit for unhealthy alcohol use (AUDIT-C, no more than two drinks a day) and cigar smoking, with nicotine replacement offeredcompletedGL-STROKE-2021, GL-USPSTF-ALCOHOL-2018, GL-TOBACCO-2021S
Yearly influenza vaccine and current COVID-19 vaccinecompletedGL-STROKE-2021, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Lower blood pressure below 130/80 mmHg without orthostatic symptoms by the eight-week review2026-08-19completedBlood pressure 128/76 mmHg on amlodipine 5 mg and lisinopril 5 mg; no orthostatic fallS
Lower LDL cholesterol below 70 mg/dL by the eight-week review2026-08-19completedLDL cholesterol 58 mg/dL on atorvastatin 80 mgS
Return to full work and public speaking by about three months after the stroke2026-10-07completedBack at full work; modified Rankin Scale 1S
Keep to no more than two drinks on any day2026-10-07activeAUDIT-C from 8 to 5; no longer drinking six or more on one occasion, but still above two drinks on some daysS
Cut down to three cigars a day as a step toward stopping2026-10-07completedThree cigars a day; not ready to stopS

Functional Status

Mental Status